The estimated Net Worth of Winston Kung is at least $689 Tisíc dollars as of 20 April 2022. Mr Kung owns over 4,000 units of Pmv Pharmaceuticals Inc stock worth over $16,006 and over the last 4 years he sold PMVP stock worth over $0. In addition, he makes $673,117 as COO & CFO at Pmv Pharmaceuticals Inc.
Mr has made over 7 trades of the Pmv Pharmaceuticals Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 4,000 units of PMVP stock worth $12,880 on 20 April 2022.
The largest trade he's ever made was exercising 5,000 units of Pmv Pharmaceuticals Inc stock on 19 August 2021 worth over $16,100. On average, Mr trades about 2,200 units every 38 days since 2020. As of 20 April 2022 he still owns at least 10,600 units of Pmv Pharmaceuticals Inc stock.
You can see the complete history of Mr Kung stock trades at the bottom of the page.
Winston Kung M.B.A. is the COO & CFO at Pmv Pharmaceuticals Inc.
As the COO & CFO of Pmv Pharmaceuticals Inc, the total compensation of Mr A at Pmv Pharmaceuticals Inc is $673,117. There are 1 executives at Pmv Pharmaceuticals Inc getting paid more, with Dr. David H. Mack Ph.D. having the highest compensation of $770,325.
Mr A is 45, he's been the COO & CFO of Pmv Pharmaceuticals Inc since . There are 5 older and 1 younger executives at Pmv Pharmaceuticals Inc. The oldest executive at Pmv Pharmaceuticals Inc is Dr. Arnold J. Levine Ph.D., 81, who is the Co-Founder, Independent Director & Member of Scientific Advisory Board.
Winston's mailing address filed with the SEC is C/O CORBUS PHARMACEUTICALS HOLDINGS, INC, 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062.
Over the last 4 years, insiders at Pmv Pharmaceuticals Inc have traded over $56,359,813 worth of Pmv Pharmaceuticals Inc stock and bought 3,910,000 units worth $70,380,000 . The most active insiders traders include Peter A. Thompson, Capital Management, L.P.Kol... a Thilo Schroeder. On average, Pmv Pharmaceuticals Inc executives and independent directors trade stock every 16 days with the average trade being worth of $130,810. The most recent stock trade was executed by Advisors Llc Orbi Med Capit... on 22 November 2023, trading 87,786 units of PMVP stock currently worth $195,763.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
Pmv Pharmaceuticals Inc executives and other stock owners filed with the SEC include: